Azzad Asset Management Inc. ADV Sells 117 Shares of The Clorox Company (NYSE:CLX)

Azzad Asset Management Inc. ADV reduced its stake in shares of The Clorox Company (NYSE:CLX) by 0.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,681 shares of the company’s stock after selling 117 shares during the quarter. Azzad Asset Management Inc. ADV’s holdings in Clorox were worth $2,554,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. CIBC Private Wealth Group LLC increased its position in shares of Clorox by 0.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock valued at $1,982,000 after buying an additional 66 shares in the last quarter. First National Bank of Mount Dora Trust Investment Services lifted its stake in Clorox by 3.2% in the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock valued at $322,000 after acquiring an additional 71 shares in the last quarter. Modera Wealth Management LLC lifted its stake in Clorox by 1.4% in the 3rd quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock valued at $672,000 after acquiring an additional 71 shares in the last quarter. Czech National Bank lifted its stake in Clorox by 0.3% in the 4th quarter. Czech National Bank now owns 21,718 shares of the company’s stock valued at $3,097,000 after acquiring an additional 71 shares in the last quarter. Finally, Global Retirement Partners LLC lifted its stake in Clorox by 7.2% in the 4th quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock valued at $156,000 after acquiring an additional 73 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have commented on CLX. Evercore ISI cut their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research note on Wednesday, May 1st. Argus upgraded Clorox to a “hold” rating in a research note on Tuesday, June 4th. Deutsche Bank Aktiengesellschaft dropped their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research note on Wednesday, April 17th. BNP Paribas assumed coverage on Clorox in a research note on Monday, June 24th. They issued an “underperform” rating and a $130.00 price target on the stock. Finally, DA Davidson restated a “neutral” rating and issued a $162.00 price target on shares of Clorox in a research note on Wednesday, April 17th. Five research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $145.33.

Clorox Stock Performance

Shares of NYSE CLX opened at $132.56 on Thursday. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The stock’s fifty day moving average price is $136.49 and its two-hundred day moving average price is $143.67. The Clorox Company has a one year low of $114.68 and a one year high of $169.14. The firm has a market cap of $16.46 billion, a price-to-earnings ratio of 68.68, a P/E/G ratio of 2.19 and a beta of 0.39.

Clorox (NYSE:CLX) last released its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.38. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. Clorox’s quarterly revenue was down 5.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.51 EPS. On average, equities analysts forecast that The Clorox Company will post 5.91 EPS for the current year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.